Chemed Ebitda from 2010 to 2024

CHE Stock  USD 570.96  7.68  1.36%   
Chemed Corp's EBITDA is increasing over the years with slightly volatile fluctuation. Overall, EBITDA is expected to go to about 423.9 M this year. During the period from 2010 to 2024 Chemed Corp EBITDA annual values regression line had geometric mean of  242,232,831 and mean square error of 2846.1 T. View All Fundamentals
 
EBITDA  
First Reported
1985-09-30
Previous Quarter
103.8 M
Current Value
117.2 M
Quarterly Volatility
59.8 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Chemed Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chemed Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 63.9 M, Interest Expense of 3.2 M or Selling General Administrative of 216.4 M, as well as many indicators such as Price To Sales Ratio of 4.08, Dividend Yield of 0.0025 or PTB Ratio of 8.34. Chemed financial statements analysis is a perfect complement when working with Chemed Corp Valuation or Volatility modules.
  
Check out the analysis of Chemed Corp Correlation against competitors.
For information on how to trade Chemed Stock refer to our How to Trade Chemed Stock guide.

Latest Chemed Corp's Ebitda Growth Pattern

Below is the plot of the Ebitda of Chemed Corp over the last few years. It is Chemed Corp's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chemed Corp's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Chemed Ebitda Regression Statistics

Arithmetic Mean273,333,517
Geometric Mean242,232,831
Coefficient Of Variation44.02
Mean Deviation102,485,084
Median217,968,000
Standard Deviation120,331,247
Sample Variance14479.6T
Range405.3M
R-Value0.90
Mean Square Error2846.1T
R-Squared0.82
Slope24,327,794
Total Sum of Squares202714.5T

Chemed Ebitda History

2024423.9 M
2023403.7 M
2022393.4 M
2021411.2 M
2020454.9 M
2019311.3 M
2018283.5 M

About Chemed Corp Financial Statements

Chemed Corp stakeholders use historical fundamental indicators, such as Chemed Corp's Ebitda, to determine how well the company is positioned to perform in the future. Although Chemed Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in Chemed Corp's assets and liabilities are reflected in the revenues and expenses on Chemed Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Chemed Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA403.7 M423.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Chemed Corp is a strong investment it is important to analyze Chemed Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Chemed Corp's future performance. For an informed investment choice regarding Chemed Stock, refer to the following important reports:
Check out the analysis of Chemed Corp Correlation against competitors.
For information on how to trade Chemed Stock refer to our How to Trade Chemed Stock guide.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemed Corp. If investors know Chemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemed Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.014
Dividend Share
1.7
Earnings Share
19.79
Revenue Per Share
157.577
Quarterly Revenue Growth
0.074
The market value of Chemed Corp is measured differently than its book value, which is the value of Chemed that is recorded on the company's balance sheet. Investors also form their own opinion of Chemed Corp's value that differs from its market value or its book value, called intrinsic value, which is Chemed Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemed Corp's market value can be influenced by many factors that don't directly affect Chemed Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemed Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemed Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemed Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.